Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Mark S Wallis , MD

Dermatology - MOHS-Micrographic Surgery โ€ข Longview, TX

Active NPI 1861489049 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

3535 N Fourth St Ste 400
Longview, TX 756050038

Call 9037573881 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

3535 N Fourth St Ste 400

Longview, TX 756050038

Telephone 9037573881
Fax 9037575948
Organization at the Same NPPES Address or Phone
Wallis Dermatology Associates Pllc Facility NPI 1396945234

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Wallis Dermatology Associates Pllc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Medical School

University Of Texas Medical School At San Antonio

Graduation Year

1988

Medicare patients

1,676 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider, 2024.

Medicare-allowed amount

About $840,434 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider and Service, 2024.

Paid by Medicare

About $643,883 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners โ€“ by Provider and Service, 2024.

30-day fills

669 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$170,378 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers โ€“ by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $2,789.60 across 141 records.

By nature of payment

  • Food and Beverage: $2,679.96 across 139 records.
  • Education: $109.64 across 2 records.

Reporting-company totals (3 largest of 18)

  • Sanofi and Genzyme US Companies: $430.74 across 17 records.
  • ABBVIE INC.: $352.54 across 28 records.
  • Bristol Myers Squibb Company: $328.26 across 18 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

38 years (graduated 1988)

CMS Doctors and Clinicians data list 1988 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.

NPI first issued

2005

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โ€œDoes your provider accept Medicare as full payment?โ€

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Wallis has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Wallis as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Longview and Texas

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 105 clinicians with data). Median for this group: 2,049. Middle half: 1,241 to 3,279.

Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 80% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 105 clinicians with data). Median for this group: $562,347. Middle half: $289,356 to $764,203.

Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 80% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 105 clinicians with data). Median for this group: $438,976. Middle half: $212,612 to $591,747.

Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 60% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 108 clinicians with data). Median for this group: 377. Middle half: 173 to 741.

Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 90% of clinicians listed under Dermatology - MOHS-Micrographic Surgery in Texas (2024, 108 clinicians with data). Median for this group: $5,017. Middle half: $2,110 to $14,930.

Too few clinicians listed under Dermatology - MOHS-Micrographic Surgery in Longview have Medicare Part D data for 2024 to compare.

2 active clinicians are listed under Dermatology - MOHS-Micrographic Surgery with a practice address in Longview, TX (122 in Texas).

Addresses are self-reported to NPPES and may be out of date.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo ยท Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments ยท Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 โ€“ December 31, 2025): 141 records totaling $2,789.60.

Manufacturer Payment Nature Product Type Amount ($)
Bristol Myers Squibb Company
Food and Beverage
Cash or cash equivalent
Sotyktu General $122.61
Sanofi and Genzyme US Companies
Education
In-kind items and services
DUPIXENT General $99.99
Kerecis Limited
Food and Beverage
Cash or cash equivalent
Kerecis SurgiClose General $49.45
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $37.68
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $37.60
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $35.73
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
โ€” General $34.91
Organon LLC
Food and Beverage
In-kind items and services
โ€” General $33.18
REVANCE THERAPEUTICS, INC.
Food and Beverage
In-kind items and services
DAXXIFY General $33.13
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
ILUMYA General $31.47
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $31.46
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $30.34
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
ILUMYA General $30.02
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $29.11
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $28.92
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $28.92
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $28.78
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $28.70
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $28.35
SUN PHARMACEUTICAL INDUSTRIES INC.
Food and Beverage
In-kind items and services
ILUMYA General $27.79
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $27.54
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $27.27
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $27.06
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $26.95
LEO Pharma Inc.
Food and Beverage
In-kind items and services
ADBRY General $26.41

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B ยท Data Year 2024
Reporting Year:

CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ€“2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ€“ by Provider and Service data, 2017โ€“2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
5,000 16 $3.00 $1.66
88305 Pathology examination of tissue using a microscope, intermediate complexity
2,171 1,291 $178.00 $67.58
17003 Destruction of precancer skin growth, 2-14 growths
1,383 193 $33.00 $6.23
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
347 264 $175.00 $86.53
17000 Destruction of precancer skin growth, 1 growth
317 223 $160.00 $47.73
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
270 204 $1570.00 $590.36
Q4229 Cogenex amniotic membrane, per square centimeter
266 18 $1795.00 $912.87
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
197 148 $250.00 $121.46
88304 Pathology examination of tissue using a microscope, moderately low complexity
156 136 $145.00 $39.99
17312 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks
129 93 $960.00 $388.47
11102 Biopsy of related skin growth, first growth
114 99 $245.00 $78.20
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm
101 91 $1145.00 $224.81
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
72 18 $10.00 $0.96
96372 Injection of drug or substance under skin or into muscle
56 23 $51.00 $13.62
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
53 47 $730.00 $252.31
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
52 37 $288.00 $95.00
11103 Biopsy of related skin growth, each additional growth
49 26 $130.00 $46.86
17110 Destruction of skin growth, 1-14 growths
44 41 $270.00 $93.02
15275 Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less
43 23 $375.00 $107.44
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
35 30 $680.00 $136.40
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
31 28 $1020.00 $227.08
11300 Shaving of skin growth of body, arms, or legs, 0.5 cm or less
29 16 $245.00 $57.26
17004 Destruction of precancer skin growth, 15 or more growths
27 23 $430.00 $158.60
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
24 21 $330.00 $118.56
14060 Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less
24 24 $1850.00 $733.96

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D ยท Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Cephalexin Cephalexin 103 618 $551.08 94
Betamethasone Dipropionate Betamethasone Dipropionate 70 1,814 $2,752.78 40
Mometasone Furoate Mometasone Furoate 63 1,659 $1,228.77 37
Doxycycline Hyclate Doxycycline Hyclate 53 2,553 $1,415.58 18
Ketoconazole Ketoconazole 31 1,015 $551.50 15
Triamcinolone Acetonide Triamcinolone Acetonide 30 806 $360.00 23
Clobetasol Propionate Clobetasol Propionate 29 1,094 $1,499.69 13
Lorazepam Lorazepam 28 56 $25.19 27
Prednisone Prednisone 27 870 $124.70 12
Amoxicillin Amoxicillin 26 65 $29.39 24
Levofloxacin Levofloxacin 21 117 $32.77 16
Minocycline Hcl Minocycline Hcl 19 539 $521.77 11
Valacyclovir Valacyclovir Hcl 18 333 $291.22 โ€”
Azithromycin Azithromycin 15 64 $31.36 13
Hydrocortisone Hydrocortisone 15 349 $143.27 โ€”
Rinvoq Upadacitinib 13 390 $83,897.29 โ€”
Hydroxychloroquine Sulfate Hydroxychloroquine Sulfate 11 330 $188.10 โ€”
Dapsone Dapsone 11 405 $702.76 โ€”
Sotyktu Deucravacitinib 11 330 $76,030.38 โ€”

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2021-07-21
Dermatology - MOHS-Micrographic Surgery Primary Specialty

NUCC Taxonomy Code: 207ND0101X

License # reported to NPPES TX H6685

The highly-trained surgeons that perform Mohs Micrographic Surgery are specialists both in dermatology and pathology. With their extensive knowledge of the skin and unique pathological skills, they are able to remove only diseased tissue, preserving healthy tissue and minimizing the cosmetic impact of the surgery. Mohs surgeons who belong to the American College of Mohs Surgery (ACMS) have completed a minimum of one year of fellowship training at one of the ACMS-approved training centers in the U.S.

Dermatology

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES TX H6685

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Dermatology - Dermatopathology

NUCC Taxonomy Code: 207ND0900X

License # reported to NPPES TX H6685

A dermatopathologist has the expertise to diagnose and monitor diseases of the skin including infectious, immunologic, degenerative and neoplastic diseases. This entails the examination and interpretation of specially prepared tissue sections, cellular scrapings and smears of skin lesions by means of routine and special (electron and fluorescent) microscopes.

Dermatology - Clinical & Laboratory Dermatological Immunology

NUCC Taxonomy Code: 207NI0002X

License # reported to NPPES TX H6685

A dermatologist who utilizes various specialized laboratory procedures to diagnose disorders characterized by defective responses of the body's immune system. Immunodermatologists also may provide consultation in the management of these disorders and administer specialized forms of therapy for these diseases.

Dermatology - Pediatric Dermatology

NUCC Taxonomy Code: 207NP0225X

License # reported to NPPES TX H6685

A pediatric dermatologist has, through additional special training, developed expertise in the treatment of specific skin disease categories with emphasis on those diseases which predominate in infants, children and adolescents.

Dermatology - Procedural Dermatology

NUCC Taxonomy Code: 207NS0135X

License # reported to NPPES TX H6685

Procedural Dermatology, a subspecialty of Dermatology, encompassing a wide variety of surgical procedures and methods to remove or modify skin tissue for health or cosmetic benefit. These methods include scalpel surgery, laser surgery, chemical surgery, cryosurgery (liquid nitrogen), electrosurgery, aspiration surgery, liposuction, injection of filler substances, and Mohs micrographic controlled surgery (a special technique for the removal of growths, especially skin cancers).

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Texas Medical Board.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
0898678-03 (TX)
Other Identifier Dps Number
30076724 (TX)
Other Identifier Clia Number
45D0684764 (TX)
Other Identifier Cidc Number
CID037095 (TX)
Other Identifier Medical License Number
H6685 (TX)
Other Identifier Med. Ed. Number
04813881913 (TX)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20100610000658

Enrollment State Jurisdiction

TX

PECOS Control ID

7113057563

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026

Wallis Dermatology Associates Pllc

1900 S Washington Ave, Marshall, TX 756706845

Phone: 9035037330

Wallis Dermatology Associates Pllc

3535 N 4th St, Longview, TX 756050036

Phone: 9037573881

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

10 listed
NPI 1154825974

Doctor of Medicine (M.D.)

Casey English , APRN-CNP

Nurse Practitioner

NPI 1780259135

Advanced Practice Registered Nurse - Certified Nurse Practitioner

NPI 1861750416

Doctor of Medicine (M.D.)

NPI 1811566250

Doctor of Medicine (M.D.)

Herold Osborne , PA-C

Physician Assistant - Medical

NPI 1710999727

Physician Assistant (Certified)

Tammi Short , FNP-C

Nurse Practitioner

NPI 1538137153

Family Nurse Practitioner (Certified)

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

8 Historical Events
๐Ÿ“
Updated Practice Location July 21, 2021

Registered at 3535 N FOURTH ST STE 400, LONGVIEW, TX 756050038 (Tel: 9037573881)

๐Ÿ“
Updated Business Mailing Address July 21, 2021

Registered at 3535 N FOURTH ST STE 400, LONGVIEW, TX 756050038 (Tel: 9037573881)

โœ…
NPI Profile Active September 18, 2012

NPI status registered as active in NPPES database

๐Ÿ“
Business Mailing Address (Initial Record) September 18, 2012

Registered at 6 DOCTOR CIR, LONGVIEW, TX 756055050 (Tel: 9037573881)

๐Ÿ“
Practice Location (Initial Record) September 18, 2012

Registered at 6 DOCTOR CIR, LONGVIEW, TX 756055050 (Tel: 9037573881)

๐Ÿ‘ค
Provider Name / Credentials (Initial Record) September 18, 2012

Recorded as MARK WALLIS, M.D.

๐ŸŽ“
Medical Taxonomy / Specialty Registered (Primary Specialty) September 18, 2012

Dermatology (license number reported to NPPES: TX H6685)

๐ŸŸข
Initial NPI Registration & Enumeration October 03, 2005

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1861489049
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: October 03, 2005
Last Update: March 07, 2023
Sole Proprietor: Yes

Mailing Address

3535 N Fourth St Ste 400

Longview, TX 756050038

Phone: 9037573881

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.